Tapok, Roberto B.
HRN: 28-24-50 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/09/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/09/2025
12/15/2025
IV
500
Q8
PUD H PYLORI
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes